Literature DB >> 19047082

Targeting the kinesin spindle protein: basic principles and clinical implications.

Vasiliki Sarli1, Athanassios Giannis.   

Abstract

Kinesin spindle protein (KSP), a member of the kinesin superfamily of microtubule-based motors, plays a critical role in mitosis as it mediates centrosome separation and bipolar spindle assembly and maintenance. Inhibition of KSP function leads to cell cycle arrest at mitosis with the formation of monoastral microtubule arrays, and ultimately, to cell death. Several KSP inhibitors are currently being studied in clinical trials and provide new opportunities for the development of novel anticancer therapeutics alternative from the available microtubule targeting drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047082     DOI: 10.1158/1078-0432.CCR-08-0120

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  45 in total

1.  Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer.

Authors:  Warefta Hasan; Kevin Chu; Anuradha Gullapalli; Stuart S Dunn; Elizabeth M Enlow; J Christopher Luft; Shaomin Tian; Mary E Napier; Patrick D Pohlhaus; Jason P Rolland; Joseph M DeSimone
Journal:  Nano Lett       Date:  2011-12-21       Impact factor: 11.189

2.  Structure-Guided Design of Novel l-Cysteine Derivatives as Potent KSP Inhibitors.

Authors:  Naohisa Ogo; Yoshinobu Ishikawa; Jun-Ichi Sawada; Kenji Matsuno; Akihiro Hashimoto; Akira Asai
Journal:  ACS Med Chem Lett       Date:  2015-07-22       Impact factor: 4.345

Review 3.  Mitosis is not a key target of microtubule agents in patient tumors.

Authors:  Edina Komlodi-Pasztor; Dan Sackett; Julia Wilkerson; Tito Fojo
Journal:  Nat Rev Clin Oncol       Date:  2011-02-01       Impact factor: 66.675

4.  Loop L5 assumes three distinct orientations during the ATPase cycle of the mitotic kinesin Eg5: a transient and time-resolved fluorescence study.

Authors:  Joseph M Muretta; William M Behnke-Parks; Jennifer Major; Karl J Petersen; Adeline Goulet; Carolyn A Moores; David D Thomas; Steven S Rosenfeld
Journal:  J Biol Chem       Date:  2013-10-21       Impact factor: 5.157

Review 5.  Mechanism and regulation of kinesin-5, an essential motor for the mitotic spindle.

Authors:  Joshua S Waitzman; Sarah E Rice
Journal:  Biol Cell       Date:  2013-11-26       Impact factor: 4.458

Review 6.  Traffic control: regulation of kinesin motors.

Authors:  Kristen J Verhey; Jennetta W Hammond
Journal:  Nat Rev Mol Cell Biol       Date:  2009-11       Impact factor: 94.444

7.  The structural basis of force generation by the mitotic motor kinesin-5.

Authors:  Adeline Goulet; William M Behnke-Parks; Charles V Sindelar; Jennifer Major; Steven S Rosenfeld; Carolyn A Moores
Journal:  J Biol Chem       Date:  2012-11-07       Impact factor: 5.157

8.  Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer.

Authors:  Robert Jones; Jacqueline Vuky; Tony Elliott; Graham Mead; José Angel Arranz; John Chester; Simon Chowdhury; Arkadiusz Z Dudek; Volker Müller-Mattheis; Marc-Oliver Grimm; Jürgen E Gschwend; Christian Wülfing; Peter Albers; Jianguo Li; Anna Osmukhina; Jeffrey Skolnik; Gary Hudes
Journal:  Invest New Drugs       Date:  2013-01-18       Impact factor: 3.850

Review 9.  Clinically Applicable Inhibitors Impacting Genome Stability.

Authors:  Anu Prakash; Juan F Garcia-Moreno; James A L Brown; Emer Bourke
Journal:  Molecules       Date:  2018-05-13       Impact factor: 4.411

10.  Synthesis of novel perillyl-dihydropyrimidinone hybrids designed for antiproliferative activity.

Authors:  Vinicius Vendrusculo; Vanessa P de Souza; Luiz Antônio M Fontoura; Marcelo G M D'Oca; Thais P Banzato; Paula A Monteiro; Ronaldo A Pilli; João Ernesto de Carvalho; Dennis Russowsky
Journal:  Medchemcomm       Date:  2018-07-31       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.